More patients with presbyopia might benefit from intraocular lenses, say experts, who report that the lenses might even be useful for patients younger than cataract age. Medscape Medical News
Retinal Gene Therapy: Long-term Results Less Than Expected
Gene therapy for RPE65-associated Leber’s congenital amaurosis enabled people to see, but the benefit diminished as photoreceptors continued to degrade in patients treated in two trials. Medscape Medical News
Uncategorized
Are you in an Alternative Payment Model? Why it matters
From international law firm Arnold & Porter LLP comes a timely column that provides views on current regulatory and legislative topics that weigh on the minds of today’s physicians and health care executives.The recently enacted Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) repealed the long-criticized Sustainable Growth Rate but added new elements to Medicare’s methods for determining physician payments (see our previous post on new payment options). Starting in 2019, a physician participating in certain “Alternative Payment Models,” or APMs, may receive a 5% bonus (2019-2024) or a (Read more...)
Makindus’ MI-100 granted EMA orphan drug designation for treatment of Stargardt’s Disease
Makindus, Inc. a specialty pharmaceutical development company focused on ophthalmology announced today that the European Medicines Agency has granted orphan drug designation for their lead candidate, MI-100, for the treatment of Stargardt’s Disease.
Uncategorized
VIDEO: Allegro Ophthalmics begins phase 2 study of Luminate for PVD
DENVER — At the Association for Research in Vision and Ophthalmology meeting here, Vicken Karageozian, MD, chief technical officer for Allegro Ophthalmics, discusses the phase 2 study of Luminate, Allegro’s integrin peptide therapy candidate for inducing posterior vitreous detachment in patients with non-proliferative diabetic retinopathy.
Uncategorized
Multicolor confocal scanning laser ophthalmoscopy may effectively detect retinal pathologies
DENVER — Multicolor confocal scanning laser ophthalmoscopy may be combined with spectral-domain OCT to detect subretinal, intraretinal and epiretinal pathology, according to a presentation here.In a poster presented at the Association for Research in Vision and Ophthalmology annual meeting, Henry Feng, MD, and colleagues discussed a retrospective review of 159 consecutive eyes that underwent multicolor confocal scanning laser ophthalmoscopy (cSLO) with SD-OCT (Spectralis, Heidelberg) in a single session.